US Drug Recall Register
Class III · Low risk Terminated Initiated Aug 4, 2016 (10 years ago)

buPROPion Hydrochloride Extended-Release Tablets, USP (XL), 300mg, 500-count bottle, Rx…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed dissolution specifications - the out of specification result for dissolution was identified during 3 month stability testing.

What was recalled

buPROPion Hydrochloride Extended-Release Tablets, USP (XL), 300mg, 500-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories, NDC 68001-264-03

Recalling firm
Amerisource Health Services
NDC code
68001-264-03
Origin
OH, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1501-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all